reference/36268043

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/36268043

Outgoing Links

Predicate	Object
contentType	Multicenter Study\|Clinical Trial, Phase II\|Journal Article\|Research Support, Non-U.S. Gov't
issn	2041-1723
issueIdentifier	1
pageRange	4904-
publicationName	Nature Communications
startingPage	4904
bibliographicCitation	Wei J, Lu X, Liu Q, Fu Y, Liu S, Zhao Y, Zhou J, Chen H, Wang M, Li L, Yang J, Liu F, Zheng L, Yin H, Yang Y, Zhou C, Zeng P, Zhou X, Ding N, Chen S, Zhao X, Yan J, Fan X, Guan W, Liu B. Neoadjuvant sintilimab in combination with concurrent chemoradiotherapy for locally advanced gastric or gastroesophageal junction adenocarcinoma: a single-arm phase 2 trial. Nat Commun. 2023 Aug 14;14(1):4904. PMID: 37580320; PMCID: PMC10425436.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-3024-8878 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-9864-1030 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d98a39404e95d3c2ba75db166dddc3c7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2f631e22b94e5dfd10967ebd27545a21 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_926e9814bfa1724280ca075b5156e178 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_98b7263943f8176cc9663b05434a2461 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f29cee2c9275f83585f1121a51c02954 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d6e904d8c330e46c3e31b7be4ad8b443 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7941fb9d8ce8bac751b2606be64e2f09 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_789ec94d4c92062d7648a8ff68f5d5e2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_765c9842c77c0a907e73ff01a4d5d566 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9c211d52b59da83f7cd0ac54d245fae0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_40c6d3601c29f574746d1021e592c4c2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0d87a44e6ce499fd03118b6389746aeb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_24d5abcd8831693ccc461585639b8d78 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c9d69a5189090479ca003003e422b938 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-2539-7732 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_68c61235c2d04751a4960e82d604a015 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d56fdb51f67eca27db57ed3f532791ae http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_645bd5c7c983695f685c121707d165d3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8408c3547e0b2ed9fe5eb24893291e50 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8066a8c1f8e11ef4d32756244ceb94d6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8c985b4a1eda91f027e3c74e61f394e4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8b8533db5d190349e88db1109bb8d66d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dff3a557580e3e1c98b20d8b030ea4a1
date	2023-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC10425436 https://doi.org/10.1038/s41467-023-40480-x https://pubmed.ncbi.nlm.nih.gov/37580320
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/37539 https://portal.issn.org/resource/ISSN/2041-1723
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Neoadjuvant sintilimab in combination with concurrent chemoradiotherapy for locally advanced gastric or gastroesophageal junction adenocarcinoma: a single-arm phase 2 trial
discusses	http://id.nlm.nih.gov/mesh/C562730 http://id.nlm.nih.gov/mesh/M000653469
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000230Q000473 http://id.nlm.nih.gov/mesh/D013274Q000473
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D004943Q000473 http://id.nlm.nih.gov/mesh/D000971Q000009 http://id.nlm.nih.gov/mesh/D020360Q000379 http://id.nlm.nih.gov/mesh/D059248Q000379 http://id.nlm.nih.gov/mesh/D017024Q000379
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36314 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_aba283fcf2192afdf79c2b7da206ab70 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_375c17477d468e8296a40307695528e6 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_118dd6abf266102dccb53d8fc658affb http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b387b380494e5b0a9f1326bde8659036 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6795 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b83d04d3e3b05ce10d1a5893dc850a9b http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_5b23d551e5b951bd68416ea80d54d341

Total number of triples: 61.